Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

  • There is currently no data for BRH

Director/PDMR Shareholding

8 Mar 2022 09:41

RNS Number : 0120E
Braveheart Investment Group plc
08 March 2022
 

8 March 2022

Braveheart Investment Group plc

("Braveheart" or the "Group")

 

Director/PDMR Shareholding

 

Notification of Transactions of Persons Discharging Managerial Responsibilities (PDMRs)

Braveheart was notified on 7 March 2022 that Trevor Brown of Braveheart, a person discharging managerial responsibilities ("PDMR") of the Company, has purchased 100,000 Ordinary Shares of 2 pence each in the Group ("Ordinary Shares") at an average price of ÂŁ0.115 per share. Trevor Brown now holds a total beneficial interest in 3,976,013 Ordinary Shares (equivalent to 7.61 per cent. of the Company's voting rights).

Details of the transaction can be found in the Notification of Dealing Form below.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Trevor Brown

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Director

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Braveheart Investment Group plc

b)

 

LEI

 

2138006HQ3COMU626I61

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 2 pence each in Braveheart Investment Group plc

 

GB00B13XV322

b)

 

Nature of the transactions

 

Purchase of ordinary shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

11.5p

 

Volume(s)

 

100,000

 

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

 

100,000

11.5p

ÂŁ11,500

e)

 

Dates of the transaction

 

7 March 2022

f)

Place of transaction

London Stock Exchange, AIM Market

 

For further information:

 

Braveheart Investment Group plcTrevor Brown, Chief Executive Officer

 

 

Tel: 01738 587555

Allenby Capital Limited (Nominated Adviser and Joint Broker) David Worlidge / George Payne

 

Tel: 020 3328 5656

 

 

Peterhouse Capital Limited (Joint Broker) Heena Karani / Lucy Williams

 

 

Tel: 020 7469 0936

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDXCXGDGDI
Date   Source Headline
19th Aug 20147:00 amRNSDirector/PDMR Shareholding
14th Aug 201412:04 pmRNSHolding(s) in Company
14th Aug 201412:04 pmRNSHolding(s) in Company
11th Aug 20147:00 amRNSIssue of Equity
22nd Jul 20143:52 pmRNSHolding(s) in Company
22nd Jul 20147:00 amRNSDirector/PDMR Shareholding
21st Jul 20147:00 amRNSPreliminary Results
3rd Apr 20143:18 pmRNSHolding(s) in Company
3rd Apr 20141:32 pmRNSHolding(s) in Company
3rd Apr 20141:30 pmRNSHolding(s) in Company
1st Apr 20147:00 amRNSTotal Voting Rights
28th Mar 201411:29 amRNSAward for WhiteRock Capital Partners
25th Mar 20147:00 amRNSIssue of Equity and Directorate Change
31st Jan 20142:58 pmRNSTotal Voting Rights
31st Jan 20147:00 amRNSHolding(s) in Company
31st Jan 20147:00 amRNSHolding(s) in Company
27th Jan 20147:00 amRNSPartnership to launch co-investment fund
14th Jan 20147:00 amRNSIssue of Equity
18th Dec 20137:00 amRNSHalf Yearly Report
13th Dec 201312:29 pmRNSDisposal
11th Dec 20137:00 amRNSFinance Yorkshire Update
6th Dec 20137:00 amRNSWhiteRock Capital Partners update
26th Sep 20132:55 pmRNSResult of AGM
16th Sep 20137:00 amRNSEnvestors funds growth at FX firm Ebury Partners
4th Sep 20137:00 amRNSNotice of AGM
3rd Sep 20137:00 amRNSFinal Results
14th Aug 20137:00 amRNSWhiteRock Capital Partners update
26th Jul 20137:00 amRNSFirst exit from fund
11th Jun 20137:00 amRNSEnvestors announces its North strategy
16th May 20137:00 amRNSBraveheart's Envestors funds payasUgym
2nd May 20137:00 amRNSBraveheart announces Envestors funding for Loco2
22nd Apr 20137:00 amRNSEnvestors leads ComparaFinanza fundraising
15th Apr 20137:00 amRNSWhiteRock Capital Partners wins key industry award
12th Apr 20137:00 amRNSReorganisation of Yorkshire businesses
2nd Apr 20133:31 pmRNSDirectorate Change - amended
2nd Apr 20137:00 amRNSDirectorate Change
19th Mar 20137:00 amRNSAdviser change of name
22nd Feb 20133:45 pmRNSUpdate on WhiteRock and Growth Loan Fund -Amend
22nd Feb 20133:02 pmRNSUpdate on WhiteRock and Growth Loan Fund
21st Feb 20137:00 amRNSEnvestors closes funding for Cipher Surgical
4th Feb 20137:00 amRNSSubsidiary and office name change
25th Jan 20137:00 amRNSEnvestors sets Fertility Focus on growth path
31st Dec 201211:15 amRNSTotal Voting Rights
19th Dec 20124:00 pmRNSIssue of Equity
14th Dec 20127:00 amRNSEnvestors members invest in eReceipts
4th Dec 20127:00 amRNSCyCell dials up Envestors for growth funding
3rd Dec 20127:00 amRNSHalf Yearly Report
28th Sep 20127:00 amRNSEnvestors closes equity funding round for Capablue
26th Sep 20127:00 amRNSAward of options
25th Sep 20122:49 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.